Information Journal Paper
APA:
Copy. (2019). Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms. Haematologica, 104(5), 937-946. SID. https://sid.ir/paper/663715/en
Vancouver:
Copy. Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms. Haematologica[Internet]. 2019;104(5):937-946. Available from: https://sid.ir/paper/663715/en
IEEE:
Copy, “Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms,” Haematologica, vol. 104, no. 5, pp. 937–946, 2019, [Online]. Available: https://sid.ir/paper/663715/en